Shinpoong Pham said it will invest about 33 billion won to build a plant producing cephalosporin antibiotics, according to a regulatory filing on January 12.
“To enter the U.S. market following the free trade agreement (FTA) ratification between the U.S and Korea, we will build a new plant,’’ a company official said.
Generic drugs made by Korean companies are not yet recognized as generic...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.